Fundz

Aprea Therapeutics reported raising $3.06 Million in an initial SEC Form D filing, from an offering of $5.78 Million

PUBLIC · APREDec 29, 2025$3.1M of $5.8M raised

Amount Raised

$3.06 Million

$3.06 Million sold, per SEC Form D (first sale Dec 10, 2025)

Round Type

Venture

DoylestownBiotechnologyHealth CareScience And EngineeringTherapeutics

Quick answer

Aprea Therapeutics raised $3.06 Million in a funding round, dated December 10, 2025. Aprea Therapeutics is based in Doylestown, Pennsylvania, United States.

How much did Aprea Therapeutics raise?
Aprea Therapeutics raised $3.06 Million in a funding round on December 10, 2025.
What does Aprea Therapeutics do?
Aprea Therapeutics (NASDAQ: APRE) is a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality.
Where is Aprea Therapeutics based and how big is it?
Aprea Therapeutics is based in Doylestown, Pennsylvania, United States.
Who are the decision-makers at Aprea Therapeutics?
Fundz holds 1 contact at Aprea Therapeutics, including the President & CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Therapeutics around the same time

Companies in the same sectors as Aprea Therapeutics that raised within 45 days of this round, from Fundz verified event records.

Who to call at Aprea Therapeutics, and when

A new round usually means Aprea Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aprea Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aprea Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aprea Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aprea Therapeutics

Location

Doylestown, Pennsylvania, United States

About

Aprea Therapeutics (NASDAQ: APRE) is a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality. We exist to ensure that cancer doesn't interrupt life's possibilities and dreams. We do this through our unique approach to synthetic lethality that is revolutionizing the future of cancer treatment.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aprea Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsNadeem M., President & CEOSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Aprea Therapeutics's next move

See what Strategic adds

Aprea Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.